Related Experiment Video
Updated: Jul 19, 2026

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 1, 2011
IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in
Y Kishihara1, J Hayashi, E Yoshimura
1Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan.
Insights
Elevated cytokine production in chronic hepatitis C patients may indicate host response to the virus. Monitoring these cytokines, alongside ALT and HCV RNA, offers a more precise measure of interferon-alpha treatment effectiveness.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Chronic hepatitis C is associated with altered immune responses.
- Interferon-alpha (IFN-α) is a standard treatment, but response varies.
- Cytokine profiles in hepatitis C patients during treatment are not fully understood.
Purpose of the Study:
- To investigate interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) production in chronic hepatitis C patients undergoing IFN-α therapy.
- To correlate cytokine levels with treatment response, viral genotype, and disease severity.
- To assess the impact of IFN-α on cytokine production.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) from chronic hepatitis C patients and healthy controls were analyzed.
- Spontaneous and phytohemagglutinin-stimulated production of IL-1β and TNF-α were measured.
- Cytokine levels were correlated with treatment outcomes (complete vs. partial response), hepatitis C virus (HCV) genotype, and histological activity index (HAI).
Main Results:
- Spontaneous IL-1β and TNF-α production were significantly higher in chronic hepatitis C patients than in healthy subjects.
- Stimulated TNF-α production was higher in complete responders compared to partial responders.
- Spontaneous cytokine production decreased in complete responders after IFN-α treatment and negatively correlated with HAI.
Conclusions:
- Elevated cytokine production in chronic hepatitis C may reflect a host immune response to the virus.
- Monitoring cytokine levels, alanine aminotransferase (ALT), and HCV RNA may enhance the assessment of IFN-α therapy effectiveness.
- Cytokine profiling could offer a more nuanced understanding of treatment response in chronic hepatitis C.
Abstract:
We investigated the spontaneous and phytohemagglutinin-stimulated production of interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) by peripheral blood mononuclear cells in patients with chronic hepatitis C during treatment with interferon-alpha (IFN-alpha). Spontaneous productions of these were significantly higher in patients with chronic hepatitis C than in healthy subjects. For patients prescribed interferon, stimulated production of TNF-alpha was significantly higher in complete responders than in partial responders, but the differences were small between the other cytokine levels and outcome of IFN treatment. Spontaneous production of these cytokines was higher in patients with genotype III with complete response than in genotype III patients with a partial response, but this was not the case in patients with genotype II. There was a negative correlation between these cytokines and histological activity index. Spontaneous production of cytokines was decreased only in complete responders after the administration of interferon. These data suggest that the elevated production of cytokines in patients with chronic hepatitis C may be due to host response to the virus, and monitoring cytokines along with alanine aminotransferase and hepatitis C virus RNA during treatment may provide more precise information of the effectiveness of therapy.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Hepatitis
Inhibitors of Viral Protein Synthesis

